Early research (Phase 1)Ended earlyNCT01906307What this trial is testingLJPC-501 in Patients With Hepatorenal SyndromeWho this might be right forHepatorenal Syndrome Type I and Type II La Jolla Pharmaceutical Company 6
Large-scale testing (Phase 3)Study completedNCT01637454What this trial is testingTYPE 2 HEPATORENAL SYNDROMEWho this might be right forSafety and Efficacy of Terlipressin and Noradrenaline and Predictive Factors of Response in Type 2 HRS Post Graduate Institute of Medical Education and Research, Chandigarh 46
Large-scale testing (Phase 3)Ended earlyNCT00742339What this trial is testingTerlipressin + Albumin Versus Midodrine + Octreotide in the Treatment of Hepatorenal SyndromeWho this might be right forCirrhosisHepatorenal Syndrome University of Padova 49
Large-scale testing (Phase 3)Study completedNCT00240045What this trial is testingThe Use of Drugs to Improve Kidney Function in Patients With Liver and Kidney DysfunctionWho this might be right forType 2 Hepatorenal SyndromeRefractory Ascites University of Alberta 9
Post-approval studies (Phase 4)UnknownNCT02489864What this trial is testingThe Effect of Terlipressin in the Prevention of Type 2 Hepatorenal Syndrome by Improving Mean Arterial PressureWho this might be right forHepatorenal Syndrome Sun Yat-sen University 30